Ketorolac tromethamine (DrugBank: Ketorolac, Tromethamine)
2 diseasesID | Disease name (Link within this page) | Number of trials |
---|---|---|
70 | Spinal stenosis | 0 |
226 | Interstitial cystitis with Hunners ulcer | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02000401 (ClinicalTrials.gov) | May 2012 | 19/11/2013 | Intranasal Ketorolac Tromethamine (Sprix) for Acute Pain of Interstitial Cystitis Flare of Pain | To Evaluate the Efficacy, Tolerability, and Safety of Intranasal Ketorolac Tromethamine (Sprix) as an Option for Acute (up to 5 Days) Pain Management Adult Interstitial Cystitis Patients Experiencing a Flare of Pain | Interstitial Cystitis | Drug: Ketorolac Tromethamine | Citrus Valley Medical Research, Inc. | NULL | Completed | 18 Years | 64 Years | Female | 15 | Phase 4 | United States |